Scrub Typhus Infection Induced Cardiovascular Disease

Sponsor
Eulji University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT03274869
Collaborator
Chungnam National University Hospital (Other), Chungbuk National University Hospital (Other)
100
2
71.9
50
0.7

Study Details

Study Description

Brief Summary

Scrub typhus infection has been considered as seasonal and endemic infectious disorder with benign feature. However, the increasing mortality rate of scrub typhus has been recently reported in Southeast Asia and cause of death could be a fetal complicating cardiovascular disease. Therefore, the association and predictors for scrub typhus induced cardiovascular disease should be investigated to provide a timely and appropriate diagnosis and to reduce the mortality rate of complicated scrub typhus infection. Therefore, investigators prospectively investigate the association and predictors of cardiovascular disease in the participants with scrub typhus infection.

Condition or Disease Intervention/Treatment Phase
  • Other: No intervention

Detailed Description

Scrub typhus is a zoonotic disease caused by Orientia tsutsugamushi confined to East Asia including South Korea. It is characterized by fever, headache, rash, and eschar and the majority of patients without complications can recover with an early diagnosis and proper management with antibiotics. However, the increasing mortality rate of scrub typhus has been recently reported in Southeast Asia. Severe complications can be manifested by respiratory distress syndrome, renal failure, hepatic failure, and cardiovascular disease. Especially, cardiovascular complications can lead to cardiogenic shock and sudden cardiac arrest. Therefore, the association and predictors for scrub typhus induced cardiovascular disease should be investigated to provide a timely and appropriate diagnosis and to reduce the mortality rate of complicated scrub typhus infection. Therefore, investigators prospectively investigate the association and predictors of cardiovascular disease in the participants with scrub typhus infection admitted to 3rd referral centers in South Korea.

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Prediction and Early Diagnosis for Cardiovascular Disease Complicated by Scrub Typhus Infection
Actual Study Start Date :
Sep 1, 2017
Anticipated Primary Completion Date :
Aug 30, 2023
Anticipated Study Completion Date :
Aug 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Scrub typhus without cardiovascular complications

Any participants with the scrub typhus infection without cardiovascular complication will be enrolled as a positive control group during admission and clinically followed by 1 year after discharge

Other: No intervention
No intervention

Scrub typhus with cardiovascular complication

Any participants with the scrub typhus infection with cardiovascular complication will be enrolled as a comparison group during admission and clinically followed by 1 year after discharge

Other: No intervention
No intervention

Outcome Measures

Primary Outcome Measures

  1. Cardiovascular Mortality [one year]

    Cardiovascular death including sudden cardiac death

Secondary Outcome Measures

  1. Cardiovascular Complications [one year]

    Atrial Fibrillation, Acute Heart Failure including acute myocarditis and Ischemic Heart Dease

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • any participants with scrub typhus infection
Exclusion Criteria:
  • patients under age of 18

  • pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Chung-Buk University Hospital Chungju Chung Chung Do Korea, Republic of 50122
2 Chung-Nam University Hospital Daejeon Chung Chung Do Korea, Republic of 50233

Sponsors and Collaborators

  • Eulji University Hospital
  • Chungnam National University Hospital
  • Chungbuk National University Hospital

Investigators

  • Principal Investigator: Hyu Ryung Cho, Chung-Ang University Hosptial, Chung-Ang University College of Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Ki-Woon Kang, MD, Professor, Chung-Ang University Hosptial, Chung-Ang University College of Medicine
ClinicalTrials.gov Identifier:
NCT03274869
Other Study ID Numbers:
  • EMC 2017-07-006-001
First Posted:
Sep 7, 2017
Last Update Posted:
Apr 1, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ki-Woon Kang, MD, Professor, Chung-Ang University Hosptial, Chung-Ang University College of Medicine
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 1, 2022